Why the study?
Defects in desmin protein can disrupt cardiac conduction signals and cause arrhythmias, prompting this report and review of cardiac involvement associated with DES mutations.
Answers are grounded in this paper and cite their sources.
This case report and literature review demonstrates that the DES c.1216C>T (p.Arg406Trp) mutation can manifest as left ventricular non-compaction and life-threatening arrhythmias requiring ICD implantation and heart transplantation, supporting the inclusion of DES in genetic screening for patients with non-compaction myocardium and early-onset conduction disease.
Desmin is a type III intermediate filament protein specifically expressed in muscle cells, which is encoded by the DES gene. Defects in the desmin protein and cytoskeletal instability may interfere with cardiac muscle conduction signals, a fundamental mechanism for arrhythmias in patients with desmin-related myopathy. This current case report presents a female patient in her early 20s who presented with early-onset complete atrioventricular block and complete left bundle branch block over the previous decade. More recently, she had developed ventricular tachycardia, ventricular fibrillation, atrial fibrillation and other arrhythmias. Echocardiography revealed non-compaction of the ventricular myocardium and pulmonary hypertension. Whole-exome sequencing analysis identified a heterozygous missense mutation in the DES gene: c.1216C>T (p.Arg406Trp). She was eventually diagnosed with arrhythmias due to desmin-related myopathy. A literature review of international databases was undertaken to summarise the clinical characteristics of the cardiac involvement associated with this DES gene mutation.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: